MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/1744666x.2019.1550359

Медицинская библиотека · Expert review of clinical immunology · 2018

Risks associated with use of TNF inhibitors in children with rheumatic diseases.

Marino Achille, Giani Teresa, Cimaz Rolando

СтатьяОбзорПеревод в очереди

Аннотация

Introduction

Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory cytokine involved in the pathogenesis of many inflammatory diseases. Several drugs blocking TNF-α are employed in clinical practice in pediatrics. Given their action on the immune system, TNF-α inhibitors have raised concerns on their safety profile since their introduction. A broad spectrum of side effects related to TNF inhibition has been reported: immunogenicity, infectious diseases, malignancies, and others. Areas covered: In order to assess the risk related to the use of anti-TNF-α agents in children with rheumatic diseases we analyzed data obtained from retrospective and prospective safety studies, case reports and case series, and controlled trials. Expert commentary: Anti-TNF-α agents have shown a remarkably good safety profile in the pediatric population so far. However, there are lots of questions to be answered and maintaining active surveillance on these drugs is necessary in order to not overlook any possible unexpected adverse effects.

Для цитирования: Marino Achille, Giani Teresa, Cimaz Rolando. Risks associated with use of TNF inhibitors in children with rheumatic diseases.. Expert review of clinical immunology. 2018. DOI: 10.1080/1744666x.2019.1550359.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.